{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2013"],"condition":["Colorectal Cancer"],"disease":["Colorectal Cancer"],"study_type":["Observational"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2626332"],"location":["Japan"],"study_start_month":["6"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Multicenter prospective observation study of salvage-line bevacizumab for unresectablemetastatic colorectal cancer in Okayama","description":"Primary outcome(s): PFS; progression-free survival","dates":{"creation":"2013-06-15"},"accession":"2626332","cross_references":{"Japan Primary Registries Network":["JPRN-UMIN000010955"]}}